See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597264_2022_Blueprint_Medicines_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001597264, Blueprint Medicines Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 554,025,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 30,700,000 |
| 3 | remainder_Assets | 667,500,000 |
| 4 | LiabilitiesCurrent | 149,765,000 |
| 5 | LiabilitiesNoncurrent | 131,725,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 105,479,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 360,397,312 |
| 9 | ResearchAndDevelopmentExpense | 1,097,421,642 |
| 10 | remainder_Expenses | 59,521,997 |
| 11 | remainder_Revenues | 550,927,124 |
| 12 | remainder_NetIncome | -4,052,465 |
| 13 | remainder_ComprehensiveNetIncome | 418,160 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,252,225,000 |
| 1 | Liabilities | 281,490,000 |
| 2 | Expenses | 1,622,819,951 |
| 3 | Revenues | 550,927,124 |
| 4 | StockholdersEquity | 970,735,000 |
| 5 | NetIncome | -1,075,945,292 |
| 6 | ComprehensiveNetIncome | -1,075,736,212 |
| 7 | BaseVar | 1,855,966,350 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.36 |
| 9 | EconomicCapitalRatio | 2.57 |